Danxi Li
12Patents
5h-index
32Co-inventors
66Inventor score
Filing activity: Jul 18, 2001 → Jul 28, 2020
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US8388965B2 | Antibodies that bind IL-4 and/or IL-13 and their uses | Emerging Cross-Sectional Technologies | 33 | Active |
| US9181349B2 | Dual variable region antibody-like binding proteins having cross-over binding region orientation | Chemistry; Metallurgy | 21 | Active |
| US9221917B2 | Dual variable region antibody-like binding proteins having cross-over binding region orientation | Chemistry; Metallurgy | 18 | Active |
| US9738728B2 | Antibodies that bind IL-4 and/or IL-13 and their uses | Emerging Cross-Sectional Technologies | 10 | Active |
| US9732162B2 | Antibodies that bind IL-4 and/or IL-13 and their uses | Emerging Cross-Sectional Technologies | 6 | Active |
| US11453727B2 | Antibodies that bind IL-4 and/or IL-13 and their uses | Emerging Cross-Sectional Technologies | 2 | Active |
| US11008389B2 | Uses of a dual V region antibody-like protein | Chemistry; Metallurgy | 1 | Active |
| US6924117B2 | Human RRP sequences and methods of use | Human Necessities | 1 | Expired |
| US10759871B2 | Antibodies that bind IL-4 and/or IL-13 and their uses | Emerging Cross-Sectional Technologies | 1 | Active |
| US7049088B2 | PRMTs as modifiers of the p53 pathway and methods of use | Physics | 0 | Expired |
| US6927022B2 | HADHs as modifiers of the p21 pathway and methods of use | Physics | 0 | Expired |
| US8153384B2 | Marks as modifiers of the p53 pathway and methods of use | Physics | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.